This 1 Sub-$20 Stock Could Beat Tesla?

From Investorplace Media | Ad

Learn about the AV tech company that’s quietly raising BILLIONS in Tesla’s shadow… while its stock still trades for under $20 a share.

Get Details HERE.

CYCC Insider Trading (Cyclacel Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.08%

Insider Buying (Last 12 Months): $18,000.00

Insider Selling (Last 12 Months): $42.84

Cyclacel Pharmaceuticals Insider Trading History Chart

Cyclacel Pharmaceuticals Share Price & Price History

^$3.62

▼ -0.03 (-0.82%)

As of 01/14/2022 01:00 AM ET

Days: 30 | 90 | 365

Free Pick from Jeff Brown: “Buy S.C.G .”

From Legacy Research | Ad

Jeff Brown picked Tesla in 2018 before it jumped 1,390%. He picked Nvidia before it jumped 3,545%. And he picked Bitcoin before it skyrocketed 22,750%.

And now he’s saying S.C.G. will be the next big tech play. He’s not the only one. Apple’s CEO even called it “the next big thing.”

Click here and get the name and ticker symbol!

Cyclacel Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/30/2021	Sam L Barker	Director	Sell	12	$3.57	$42.84
11/18/2021	Spiro George Rombotis	CEO	Buy	4,000	$4.50	$18,000.00

Insider Selling at Cyclacel Pharmaceuticals?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Cyclacel Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Cyclacel Pharmaceuticals (NASDAQ:CYCC)

37.00% of Cyclacel Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cyclacel Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2021	Two Sigma Advisers LP	121,500	$0.64M	0.0%	+929.7%	1.316%
11/16/2021	Two Sigma Investments LP	30,221	$0.16M	0.0%	-35.8%	0.327%
11/15/2021	Pura Vida Investments LLC	105,141	$0.55M	0.0%	-33.2%	1.139%
11/15/2021	Morgan Stanley	112,221	$0.59M	0.0%	-7.5%	1.215%
11/15/2021	Tri Locum Partners LP	522,943	$2.76M	1.1%	+66.9%	5.663%
11/15/2021	Dimensional Fund Advisors LP	13,963	$74K	0.0%	N/A	0.151%
11/12/2021	Affinity Asset Advisors LLC	400,000	$2.11M	0.5%	+5.3%	4.332%
11/12/2021	Geode Capital Management LLC	58,934	$0.31M	0.0%	+15.9%	0.638%
11/2/2021	Raymond James Financial Services Advisors Inc.	10,006	$53K	0.0%	-83.3%	0.108%
10/15/2021	NEXT Financial Group Inc	14,752	$77K	0.0%	+70.0%	0.160%
8/23/2021	Morgan Stanley	121,275	$0.72M	0.0%	+21.3%	1.313%
8/18/2021	Ikarian Capital LLC	100,000	$0.59M	0.0%	-66.7%	1.083%
8/17/2021	Boothbay Fund Management LLC	10,545	$62K	0.0%	-66.7%	0.114%
8/17/2021	Citadel Advisors LLC	250,797	$1.49M	0.0%	-14.7%	2.716%
8/16/2021	Tri Locum Partners LP	313,331	$1.86M	0.6%	+6.8%	3.393%
8/16/2021	Morgan Stanley	121,275	$0.72M	0.0%	+21.3%	1.313%
8/16/2021	Schonfeld Strategic Advisors LLC	102,525	$0.61M	0.0%	-25.0%	1.110%
8/16/2021	Maven Securities LTD	234,500	$1.43M	0.1%	-6.2%	2.540%
8/13/2021	Northern Trust Corp	14,957	$89K	0.0%	N/A	0.162%
8/13/2021	Geode Capital Management LLC	50,860	$0.30M	0.0%	+143.3%	0.551%
8/13/2021	Vanguard Group Inc.	327,658	$1.94M	0.0%	+9.2%	3.548%
7/31/2021	NEXT Financial Group Inc	8,680	$51K	0.0%	N/A	0.094%
5/19/2021	Virtu Financial LLC	13,108	$93K	0.0%	+27.3%	0.142%
5/19/2021	Squarepoint Ops LLC	23,836	$0.17M	0.0%	N/A	0.258%
5/18/2021	Point72 Asset Management L.P.	230,000	$1.64M	0.0%	N/A	2.491%
5/18/2021	Verition Fund Management LLC	116,674	$0.83M	0.0%	N/A	1.264%
5/18/2021	Morgan Stanley	100,000	$0.71M	0.0%	-13.0%	1.083%
5/18/2021	Citadel Advisors LLC	293,867	$2.09M	0.0%	N/A	3.182%
5/18/2021	Silverarc Capital Management LLC	250,000	$1.78M	1.0%	N/A	2.707%
5/17/2021	Schonfeld Strategic Advisors LLC	136,725	$0.97M	0.0%	N/A	1.481%
5/17/2021	Sphera Funds Management LTD.	508,322	$3.61M	0.3%	N/A	5.505%
5/17/2021	Ikarian Capital LLC	300,000	$2.13M	0.1%	-23.4%	3.249%
5/12/2021	Geode Capital Management LLC	20,904	$0.15M	0.0%	N/A	0.226%
5/12/2021	Pura Vida Investments LLC	273,958	$1.95M	0.1%	-42.3%	2.967%
5/11/2021	Acadian Asset Management LLC	34,057	$0.24M	0.0%	N/A	0.369%
4/12/2021	Valeo Financial Advisors LLC	4,500	$32K	0.0%	N/A	0.063%
2/24/2021	Virtu Financial LLC	10,293	$80K	0.0%	N/A	0.212%
2/16/2021	Pura Vida Investments LLC	475,000	$3.71M	0.1%	N/A	9.766%
2/16/2021	Acuta Capital Partners LLC	150,000	$1.17M	0.3%	N/A	3.084%
2/12/2021	Raymond James Financial Services Advisors Inc.	57,006	$0.45M	0.0%	+24.6%	1.172%
2/12/2021	Ikarian Capital LLC	391,450	$3.06M	0.1%	N/A	8.048%
11/4/2020	Raymond James Financial Services Advisors Inc.	45,756	$0.17M	0.0%	+48.8%	0.941%
7/17/2020	Raymond James Financial Services Advisors Inc.	30,756	$0.14M	0.0%	-48.8%	0.633%
7/16/2020	Wedbush Securities Inc.	29,300	$0.14M	0.0%	N/A	0.603%
2/13/2020	Renaissance Technologies LLC	1,269,326	$0.85M	0.0%	+8.4%	7.380%
2/12/2020	Raymond James Financial Services Advisors Inc.	60,125	$40K	0.0%	-20.0%	0.350%
2/4/2020	Virtu Financial LLC	50,232	$34K	0.0%	+90.3%	0.292%
8/12/2019	Renaissance Technologies LLC	1,102,400	$0.60M	0.0%	+82.5%	6.409%
8/13/2018	Renaissance Technologies LLC	91,400	$0.13M	0.0%	+513.4%	0.762%
2/14/2018	Two Sigma Investments LP	70,310	$0.12M	0.0%	N/A	0.591%
2/9/2018	Citadel Advisors LLC	61,900	$0.11M	0.0%	N/A	0.520%
2/9/2018	Virtu Financial LLC	199,464	$0.35M	0.0%	+69.5%	1.676%
8/14/2017	Tang Capital Management LLC	559,900	$2.11M	0.7%	No Change	0.000%

Data available starting January 2016

Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.

Today's Range

Now: $3.62

$3.50

$3.65

50 Day Range

MA: $3.89

$3.24

$5.10

52 Week Range

Now: $3.62

$3.15

$11.42

Volume

52,482 shs

Average Volume

96,060 shs

Market Capitalization

$36.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.13

Who are the company insiders with the largest holdings of Cyclacel Pharmaceuticals?: Cyclacel Pharmaceuticals' top insider investors include:
Sam L Barker (Director)
Spiro George Rombotis (CEO)

3 Cryptos to Buy for 2022

From Investor Place Media | Ad

Is your crypto portfolio ready for 2022?

With Bitcoin hitting all-time highs, now is the time to reorient your crypto plays for the coming year.

That's why Luke Lango, InvestorPlace's resident crypto expert is releasing his latest calls… completely free.

You can get them in his latest report, "3 Cryptos to Beat Bitcoin."

Just click here to claim your copy today.